-+ 0.00%
-+ 0.00%
-+ 0.00%

AbCellera Biologics's Earnings Outlook

Benzinga·02/23/2026 21:02:22
Listen to the news

AbCellera Biologics (NASDAQ:ABCL) is set to give its latest quarterly earnings report on Tuesday, 2026-02-24. Here's what investors need to know before the announcement.

Analysts estimate that AbCellera Biologics will report an earnings per share (EPS) of $-0.18.

Investors in AbCellera Biologics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Earnings History Snapshot

In the previous earnings release, the company missed EPS by $0.02, leading to a 13.69% drop in the share price the following trading session.

Here's a look at AbCellera Biologics's past performance and the resulting price change:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.17 -0.17 -0.14 -0.15
EPS Actual -0.19 -0.12 -0.15 -0.12
Price Change % -14.00 0.00 1.00 -11.00

eps graph

Stock Performance

Shares of AbCellera Biologics were trading at $3.04 as of February 20. Over the last 52-week period, shares are up 7.09%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for AbCellera Biologics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.